6 research outputs found
MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia
The most widely accepted hypothesis for the development of glioblastoma suggests that
glioblastoma stem-like cells (GSCs) are crucially involved in tumor initiation and recurrence as
well as in the occurrence of chemo- and radio-resistance. Mesenchyme homeobox 2 (MEOX2) is a
transcription factor overexpressed in glioblastoma, whose expression is negatively correlated with
patient survival. Starting from our observation that MEOX2 expression is strongly enhanced in six
GSC lines, we performed shRNA-mediated knock-down experiments in two different GSC lines and
found that MEOX2 depletion resulted in the inhibition of cell growth and sphere-forming ability
and an increase in apoptotic cell death. By a deep transcriptome analysis, we identified a core group
of genes modulated in response to MEOX2 knock-down. Among these genes, the repressed ones
are largely enriched in genes involved in the hypoxic response and glycolytic pathway, two strictly
related pathways that contribute to the resistance of high-grade gliomas to therapies. An in silico
study of the regulatory regions of genes differentially expressed by MEOX2 knock-down revealed
that they mainly consisted of GC-rich regions enriched for Sp1 and Klf4 binding motifs, two main
regulators of metabolism in glioblastoma. Our results show, for the first time, the involvement of
MEOX2 in the regulation of genes of GSC metabolism, which is essential for the survival and growth
of these cells
In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4+ T Cells Harboring Reactivated Human Immunodeficiency Virus
In the attempt of purging the HIV-1 reservoir through the “shock-and-kill” strategy, it is important to select latency-reversing agents (LRAs) devoid of deleterious effects on the antiviral function of immune effector cells. Here, we investigated two LRAs with PKC agonist activity, prostratin (PRO) and bryostatin-1 (BRY), for their impact on the function of natural killer (NK) cells, the major effectors of innate immunity whose potential in HIV-1 eradication has emerged in recent clinical trials. Using NK cells of healthy donors, we found that exposure to either PRO or BRY potently activated NK cells, resulting in upmodulation of NKG2D and NKp44 activating receptors and matrix metalloprotease-mediated shedding of CD16 receptor. Despite PRO and BRY affected NK cell phenotype in the same manner, their impact on NK cell function was diverse and showed considerable donor-to-donor variation. Altogether, in most tested donors, the natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) of NK cells were either improved or maintained by PRO, while both activities were impaired by BRY. Moreover, we analyzed the effect of these drugs on the capacity of treated NK cells to kill autologous latently infected CD4+ T cells reactivated via the same treatment. First, we found that PRO but not BRY increased upmodulation of the ULBP2 ligand for NKG2D on reactivated p24+ cells. Importantly, we showed that clearance of reactivated p24+ cells by NK cells was enhanced when both targets and effectors were exposed to PRO but not to BRY. Overall, PRO had a superior potential compared with BRY as to the impact on key NK cell functions and on NK-cell-mediated clearance of the HIV-1 reservoir. Our results emphasize the importance of considering the effects on NK cells of candidate “shock-and-kill” interventions. With respect to combinative approaches, the impact on NK cells of each LRA should be re-evaluated upon combination with a second LRA, which may have analogous or opposite effects, or with immunotherapy targeting NK cells. In addition, avoiding co-administration of LRAs that negatively impact ADCC activity by NK cells might be essential for successful application of antibodies or vaccination to “shock-and-kill” strategies
New insight into the function of sperm retained histones.
We previously demonstrated that the nuclear form of Glutathione Peroxidase 4 (nGPx4) has a peculiar distribution in sperm head and is required for proper paternal chromatin decondensation at fertilization. While protamines are the major component responsible for sperm chromatin packaging, a small amount of histones is also retained, the relevant role of which has been recently highlighted in influencing early embryo development. We hypothesized that paternal histone modifications are implicated in the process of sperm chromatin disassembly in the zygote, addressing this issue in nGPx4 KO mice as experimental model. We first assessed the presence of acetylated histones in cauda epididymal sperm from WT mouse and by immunofluorescence we were then able to detect hyperacetylated histone H4 in mature sperm partially decondensed by treatment with glutathione and heparin. Western blot analysis of hyperacetylated histone H4 and histone H3 acetylated at K9 and K14 showed significant higher amounts of modified histones in nGPx4 KO sperm compared to WT sperm. When WT sperm chromatin status was analyzed in zona pellucida free oocytes fertilized in vitro in the presence of trichostatin (TSA), a faster decondensation kinetics was observed compared to untreated sperm. Having a higher content of acetylated histones, nGPx4 KO sperm did not show any decondensation following TSA treatment. In addition the analysis of DNA methylation pattern of the paternally imprinted gene Igf2/H19 showed a significant hypomethylation in KO sperm compared to WT ones. These findings reveal a link between acetylated histones retained in sperm and paternal chromatin remodeling after fertilization
NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells
HIV-1-infected patients failing to recover CD4+ T-cell count despite HAART (immunological non-responders, NRs), are at increased risk of disease progression and death. To better understand the NR status, we performed a comprehensive assessment of NK cells in NR patients as compared to immunologic responders. NRs exhibited an accumulation of CD56bright NK cells inversely correlated with CD4+ counts. Both CD56bright and CD56dim NK cells of NRs displayed unimpaired degranulation ability, but poorly responded to cytokine stimulation in terms of NKp44 up-regulation and IFN-γ production that may explain the susceptibility of NRs to infections and tumors. Notably, CD56bright NK cells from NRs showed higher cytotoxicity against autologous activated CD4+ T cells. Moreover, NRs had reduced Treg cell counts that showed an inverse correlation with autoreactive CD56bright cells. These data suggest that accumulation of CD56bright NK cells, possibly linked to decreased homeostatic control by Tregs, contributes to poor immune reconstitution in NRs
Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia
Ataxia-telangiectasia (A-T) is a multisystem disorder caused by biallelic pathogenic variants in the gene encoding A-T mutated (ATM) kinase, a master regulator of the DNA damage response (DDR) pathway. Most A-T patients show cellular and/or humoral immunodeficiency that has been associated with cancer risk and reduced survival, but NK cells have not been thoroughly studied. Here we investigated NK cells of A-T patients with a special focus on the NKG2D receptor that triggers cytotoxicity upon engagement by its ligands (NKG2DLs) commonly induced via the DDR pathway on infected, transformed, and variously stressed cells. Using flow cytometry, we examined the phenotype and function of NK cells in 6 A-T patients as compared with healthy individuals. NKG2D expression was evaluated also by western blotting and RT-qPCR; plasma soluble NKG2DLs (sMICA, sMICB, sULBP1, ULBP2) were measured by ELISA. Results showed that A-T NK cells were skewed towards the CD56neg anergic phenotype and displayed decreased expression of NKG2D and perforin. NKG2D was reduced at the protein but not at the mRNA level and resulted in impaired NKG2D-mediated cytotoxicity in 4/6 A-T patients. Moreover, in A-T plasma we found 24-fold and 2-fold increase of sMICA and sULBP1, respectively, both inversely correlated with NKG2D expression. Overall, NK cells are disturbed in A-T patients showing reduced NKG2D expression, possibly caused by persistent engagement of its ligands, that may contribute to susceptibility to cancer and infections and represent novel targets for therapeutic interventions